Skip to main content
Top
Published in: Journal of Gastroenterology 3/2019

Open Access 01-03-2019 | Original Article—Alimentary Tract

Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)

Authors: Kimberley Wilhelmina Johanna van der Sloot, Rinse Karel Weersma, Gerard Dijkstra, Behrooz Zaid Alizadeh

Published in: Journal of Gastroenterology | Issue 3/2019

Login to get access

Abstract

Background

In the complex etiology of inflammatory bowel disease (IBD), the exposome is a major contributor. Though many environmental exposures have been identified, quality of evidence varies greatly and overall evidence for the exposome is inconclusive. A universal, precise, and reproducible measurement tool is needed to study the exposome in IBD.

Methods

We built the web-based Groningen IBD Environmental Questionnaire (GIEQ), an extensive and structured questionnaire measuring potentially involved environmental exposures, consisting of 848 items, subdivided into 15 categories. For validation, 76 IBD patients completed the GIEQ twice (2-month interval). Cohen’s kappa and correlation coefficients were used to compare both fills. Internal consistency was evaluated using Cronbach’s alpha tests. Proportional bias was examined using Bland–Altman plots.

Results

In general, we obtained a mean kappa coefficient of 0.78 (standard deviation 0.17) for categorical questions and a mean intraclass correlation coefficient of 0.88 (0.15) for numeric questions. Cronbach’s alpha ranged from 0.64 to 1.0 with a mean of 0.79 (0.14). Bland–Altman plots showed proportional bias only for current physical activity score.

Conclusions

The GIEQ is a reliable measurement tool to study the exposome in IBD, enabling consistent measurement of an extended number of environmental factors and their interactions. Use of the GIEQ across IBD cohorts will lead to more standardized, generalizable, and comparable results. Also, the GIEQ can be used for calculation of an exposome risk score, applicable for secondary prevention by identifying high-risk patients as well as to analyze interactions between the exposome and other aspects of IBD etiology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cosnes J, Gowerrousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–94.CrossRefPubMed Cosnes J, Gowerrousseau C, Seksik P, et al. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–94.CrossRefPubMed
2.
go back to reference Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24.CrossRefPubMedPubMedCentral Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491:119–24.CrossRefPubMedPubMedCentral
3.
go back to reference Liu JZ, Van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–86.CrossRefPubMedPubMedCentral Liu JZ, Van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–86.CrossRefPubMedPubMedCentral
4.
go back to reference Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–17.CrossRefPubMed Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–17.CrossRefPubMed
5.
go back to reference Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomark Prev. 2005;14:1847–50.CrossRef Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomark Prev. 2005;14:1847–50.CrossRef
6.
go back to reference Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. YGAST. 2012;142(46–54):e42. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. YGAST. 2012;142(46–54):e42.
7.
go back to reference van der Sloot KWJ, Amini M, Peters V, et al. Inflammatory bowel diseases: review of known environmental protective and risk factors involved. Inflamm Bowel Dis. 2017;23(9):1499–509.CrossRefPubMed van der Sloot KWJ, Amini M, Peters V, et al. Inflammatory bowel diseases: review of known environmental protective and risk factors involved. Inflamm Bowel Dis. 2017;23(9):1499–509.CrossRefPubMed
8.
go back to reference Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–71.CrossRefPubMed Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–71.CrossRefPubMed
9.
go back to reference Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:339–46. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010;6:339–46.
10.
go back to reference Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.CrossRefPubMed Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.CrossRefPubMed
11.
go back to reference Klement E, Lysy J, Hoshen M, et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008;103:1775–82.CrossRefPubMed Klement E, Lysy J, Hoshen M, et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008;103:1775–82.CrossRefPubMed
12.
go back to reference Luther J, Dave M, Higgins PDR, et al. Association between Helicobacter pylori infection and inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1077–84.CrossRefPubMed Luther J, Dave M, Higgins PDR, et al. Association between Helicobacter pylori infection and inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1077–84.CrossRefPubMed
13.
go back to reference Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 1994;343:766–7.CrossRefPubMed Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 1994;343:766–7.CrossRefPubMed
14.
go back to reference Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687–92.CrossRefPubMed Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol. 2010;105:2687–92.CrossRefPubMed
15.
go back to reference Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Hormone therapy increases risk of ulcerative colitis but not crohn’s disease. Gastroenterology. 2012;143:1199–206.CrossRefPubMed Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Hormone therapy increases risk of ulcerative colitis but not crohn’s disease. Gastroenterology. 2012;143:1199–206.CrossRefPubMed
16.
go back to reference Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62:1153–9.CrossRefPubMed Khalili H, Higuchi LM, Ananthakrishnan AN, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62:1153–9.CrossRefPubMed
17.
go back to reference Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn’s disease ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350–9.CrossRefPubMedPubMedCentral Ananthakrishnan AN, Higuchi LM, Huang ES, et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn’s disease ulcerative colitis: a cohort study. Ann Intern Med. 2012;156:350–9.CrossRefPubMedPubMedCentral
18.
go back to reference Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–71.CrossRefPubMed Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81:1462–71.CrossRefPubMed
19.
go back to reference Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ. 2013;347:f6633.CrossRefPubMedPubMedCentral Khalili H, Ananthakrishnan AN, Konijeti GG, et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ. 2013;347:f6633.CrossRefPubMedPubMedCentral
20.
go back to reference Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61:1686–92.CrossRefPubMed Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, et al. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012;61:1686–92.CrossRefPubMed
21.
go back to reference Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142:482–9.CrossRefPubMed Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology. 2012;142:482–9.CrossRefPubMed
22.
go back to reference Kaplan GG, Hubbard J, Korzenik J, et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010;105:2412–9.CrossRefPubMedPubMedCentral Kaplan GG, Hubbard J, Korzenik J, et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010;105:2412–9.CrossRefPubMedPubMedCentral
23.
go back to reference Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.CrossRefPubMed Klement E, Cohen RV, Boxman J, et al. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.CrossRefPubMed
24.
go back to reference Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156–67.CrossRefPubMedPubMedCentral Cleynen I, Boucher G, Jostins L, et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet. 2016;387:156–67.CrossRefPubMedPubMedCentral
25.
go back to reference Ananthakrishnan AN. The exposome in inflammatory bowel disease. Trop Gastroenterol. 2014;35:135–40.CrossRefPubMed Ananthakrishnan AN. The exposome in inflammatory bowel disease. Trop Gastroenterol. 2014;35:135–40.CrossRefPubMed
26.
go back to reference Scholtens S, Smidt N, Swertz MA, et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44:1172–80.CrossRefPubMed Scholtens S, Smidt N, Swertz MA, et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int J Epidemiol. 2015;44:1172–80.CrossRefPubMed
27.
go back to reference Landis JR, Koch GG. The measurement of observer agreement for categorical data. Int Biom Soc. 2008;33:159–74. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Int Biom Soc. 2008;33:159–74.
28.
go back to reference Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.CrossRef Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.CrossRef
29.
go back to reference McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.CrossRef McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22:276–82.CrossRef
30.
go back to reference Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25:141–51.CrossRef Giavarina D. Understanding Bland Altman analysis. Biochem Med. 2015;25:141–51.CrossRef
31.
go back to reference Wendel-Vos GCW, Schuit AJ, Saris WHM, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56:1163–9.CrossRefPubMed Wendel-Vos GCW, Schuit AJ, Saris WHM, Kromhout D. Reproducibility and relative validity of the short questionnaire to assess health-enhancing physical activity. J Clin Epidemiol. 2003;56:1163–9.CrossRefPubMed
33.
go back to reference Suenaert P, Bulteel V, den Hond E, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther. 2000;14:819–22.CrossRefPubMed Suenaert P, Bulteel V, den Hond E, et al. The effects of smoking and indomethacin on small intestinal permeability. Aliment Pharmacol Ther. 2000;14:819–22.CrossRefPubMed
34.
go back to reference Araki M, Shinzaki S, Yamada T, et al. Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease. J Gastroenterol. 2007;52:1149–57.CrossRef Araki M, Shinzaki S, Yamada T, et al. Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease. J Gastroenterol. 2007;52:1149–57.CrossRef
Metadata
Title
Development and validation of a web-based questionnaire to identify environmental risk factors for inflammatory bowel disease: the Groningen IBD Environmental Questionnaire (GIEQ)
Authors
Kimberley Wilhelmina Johanna van der Sloot
Rinse Karel Weersma
Gerard Dijkstra
Behrooz Zaid Alizadeh
Publication date
01-03-2019
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 3/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-1501-z

Other articles of this Issue 3/2019

Journal of Gastroenterology 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine